The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.
暂无分享,去创建一个
E. Antman | E. Braunwald | S. Murphy | J. López-Sendón | H. Hod | K. Fox | G. Montalescot | S. Agewall | F. Verheugt | B. Somaraju
[1] Timi Study,et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction , 2006 .
[2] S. Yusuf,et al. Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction: A Meta-Analysis of the Randomized Trials , 2005, Circulation.
[3] R. Collins,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[4] F. Van de Werf,et al. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. , 2005, European heart journal.
[5] E. Antman,et al. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (E , 2005, American heart journal.
[6] Timi Study,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation , 2005 .
[7] E. Antman,et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. , 2004, European heart journal.
[8] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[9] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[10] Á. Avezum,et al. A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry , 2004 .
[11] E. Antman,et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. , 2003, Journal of the American College of Cardiology.
[12] J. Gore,et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) , 2003, Heart.
[13] R. Kronmal,et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.
[14] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.
[15] A. Jaffe,et al. Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.
[16] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.
[17] D C Wheeler,et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Assent investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction , 2001, The Lancet.
[19] G. Montalescot,et al. Enoxaparin in unstable angina patients with renal failure. , 2001, International journal of cardiology.
[20] E. Antman,et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.
[21] D. Cerne,et al. MILDLY ELEVATED SERUM CREATININE CONCENTRATION CORRELATES WITH THE EXTENT OF CORONARY ATHEROSCLEROSIS , 2000, Renal failure.
[22] D. Levy,et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.
[23] D. Levy,et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. , 1999, Archives of internal medicine.
[24] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[25] L. Ferrucci,et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. , 1998, Archives of internal medicine.
[26] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .